Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

被引：0

作者：

Chris Skedgel

Daniel Rayson

Tallal Younis

机构：

[1] University of East Anglia,Norwich Medical School

[2] Capital Health,Atlantic Clinical Cancer Research Unit

[3] Capital Health,Department of Medicine

来源：

Supportive Care in Cancer | 2016年 / 24卷

关键词：

Breast cancer; Febrile neutropenia; Granulocyte colony-stimulating factors; Economic evaluation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：387 / 394

页数：7

共 50 条

[1] Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
Skedgel, Chris
Rayson, Daniel
Younis, Tallal
SUPPORTIVE CARE IN CANCER, 2016, 24 (01) : 387 - 394
[2] Prophylaxis of Febrile Neutropenia with granulocyte-colony stimulating factor
Takamatsu, Yasushi
ANNALS OF ONCOLOGY, 2015, 26 : 59 - 59
[3] Febrile neutropenia primary prophylaxis with granulocyte-colony stimulating factors (G-CSF) in breast cancer
Younis, T.
Rayson, D.
Skedgel, C.
CANCER RESEARCH, 2013, 73
[4] A Comparison of Brand and Biosimilar Granulocyte-Colony Stimulating Factors for Prophylaxis of Chemotherapy-Induced Febrile Neutropenia
Douglas, Andrea G.
Schwab, Phil
Lane, Daniel
Kennedy, Kenneth
Slabaugh, S. Lane
Bowe, Andy
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (12): : 1221 - 1226
[5] COST-UTILITY OF GRANULOCYTE-COLONY STIMULATING FACTORS FOR PRIMARY PROPHYLAXIS OF CHEMOTHERAPY INDUCED FEBRILE NEUTROPENIA IN BREAST CANCER PATIENTS IN BELGIUM
Somers, L.
Malfait, M.
Danel, A.
VALUE IN HEALTH, 2012, 15 (07) : A427 - A427
[6] Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review
Lapidari, Pietro
Vaz-Luis, Ines
Di Meglio, Antonio
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
[7] A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens
Zardawi, Sarah J.
Nordman, Ina
Zdenkowski, Nicholas
CANCER REPORTS, 2020, 3 (05)
[8] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
Sol Cortés de Miguel
Miguel Ángel Calleja-Hernández
Salomón Menjón-Beltrán
Inmaculada Vallejo-Rodríguez
Supportive Care in Cancer, 2015, 23 : 547 - 559
[9] Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia
Cortes de Miguel, Sol
Angel Calleja-Hernandez, Miguel
Menjon-Beltran, Salomon
Vallejo-Rodriguez, Inmaculada
SUPPORTIVE CARE IN CANCER, 2015, 23 (02) : 547 - 559
[10] Review of practice patterns of primary granulocyte-colony stimulating factor prophylaxis and impact on febrile neutropenia rate and chemotherapy delivery in patients with early breast cancer treated with modern adjuvant chemotherapy.
Mates, Mihaela
Hopman, Wilma
Altwairgi, Abdullah Khalaf
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)

← 1 2 3 4 5 →